FCM
MDCO

Frontier Capital Management’s Medicines Co MDCO Stock Holding History

Frontier Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-709,229
Closed -$27M – 332
2017
Q2 		$27M Buy
709,229
+105,209
+17% +$4.69M 0.2% 162
2017
Q1 		$29.5M Buy
604,020
+352,230
+140% +$16.1M 0.22% 158
2016
Q4 		$8.55M Buy
251,790
+210,371
+508% +$7.46M 0.07% 244
2016
Q3 		$1.56M Sell
41,419
-9,110
-18% -$343K 0.01% 286
2016
Q2 		$1.7M Sell
50,529
-9,895
-16% -$349K 0.01% 285
2016
Q1 		$1.92M Sell
60,424
-226,135
-79% -$7.39M 0.02% 288
2015
Q4 		$10.7M Sell
286,559
-430,153
-60% -$16.3M 0.09% 244
2015
Q3 		$27.2M Sell
716,712
-539,941
-43% -$19M 0.23% 156
2015
Q2 		$36M Sell
1,256,653
-1,058,255
-46% -$29.5M 0.26% 140
2015
Q1 		$64.9M Buy
2,314,908
+986,310
+74% +$27.7M 0.47% 64
2014
Q4 		$36.8M Buy
+1,328,598
New +$32.9M 0.27% 133
2014
Q3 		– Sell
-209,341
Closed -$6.08M – 351
2014
Q2 		$6.08M Sell
209,341
-1,273,878
-86% -$34M 0.04% 275
2014
Q1 		$42.2M Sell
1,483,219
-263,710
-15% -$8.73M 0.31% 123
2013
Q4 		$67.5M Buy
1,746,929
+899,379
+106% +$32.2M 0.5% 52
2013
Q3 		$28.4M Buy
+847,550
New +$27M 0.22% 158

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Frontier Capital Management's MDCO Position: Q3 2017 in Review

Frontier Capital Management sold out of Medicines Co (MDCO) in Q3 2017, closing a stake of 709,229 shares — an estimated $27M sold.

Frontier Capital Management first reported a position in MDCO in Q3 2013 and held it in 15 quarters. The position peaked at $67.5M in Q4 2013. 190 funds tracked by Wall St. Rank hold MDCO as of Q3 2017.

  • Frontier Capital Management reported no remaining Medicines Co position as of Q3 2017 after selling out during the quarter.
  • Frontier Capital Management sold 709,229 Medicines Co shares in Q3 2017, an estimated $27M.
  • Frontier Capital Management first reported a position in Medicines Co in Q3 2013 and held it in 15 quarters.
  • Frontier Capital Management's Medicines Co position peaked at $67.5M in Q4 2013.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q3 2017.

Based on Frontier Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.